Etiket: generics
Novartis shares make profits: Novartis launches Sandoz generics division – IPO planned for 2023
The IPO is planned for the second half of 2023, Novartis announced on Thursday. Sandoz includes Novartis’ biosimilars and over-the-counter medicines businesses. Novartis announced in October 2021 that it would…